Hasil Pencarian - Nesreen Ismail
- Menampilkan 1 - 6 hasil dari 6
-
1
-
2
715 WTX-330 is an IL-12 pro-drug that is conditionally activated within the tumor microenvironment and induces regressions in mouse tumor models oleh Christopher Nirschl, Kristin Morris, Heather Brodkin, Daniel Hicklin, Nesreen Ismail, Andres Salmeron, Philipp Steiner, Zoe Steuert, Jenna Sullivan, William Winston
Diterbitkan 2021-11-01Artikel -
3
718 WTX-124 is a novel IL-2 pro-drug that is conditionally activated in tumors and drives antitumor immunity in murine syngeneic cancer models oleh Christopher Nirschl, Kristin Morris, Heather Brodkin, Daniel Hicklin, Nesreen Ismail, Andres Salmeron, Philipp Steiner, Zoe Steuert, Jenna Sullivan, William Winston, Cindy Seidel-Dugan
Diterbitkan 2021-11-01Artikel -
4
1075 Development of WTX-712, a conditionally active IL-21 INDUKINETM molecule for the treatment of cancer oleh Kyriakos Economides, Nesreen Ismail, Andres Salmeron, Jenna M Sullivan, Pam Aderhold, Heather R Brodkin, Celesztina Nagy-Domonkos, Daniel J Hicklin, Cynthia Seidel-Dugan, William M Winston
Diterbitkan 2023-11-01Artikel -
5
1058 Optimal antitumor immunity triggered by WTX-124, a clinical stage conditionally activated INDUKINETM molecule that releases fully potent IL-2 in the tumor microenvironment oleh Christopher J Nirschl, Nesreen Ismail, Andres Salmeron, Zoe Steuert, Jenna M Sullivan, Heather R Brodkin, Daniel J Hicklin, Cynthia Seidel-Dugan, William M Winston, Yuka Lewis
Diterbitkan 2023-11-01Artikel -
6
723 WTX-613, a conditionally activated IFNα INDUKINE™ molecule, induces anti-tumor immune responses resulting in strong tumor growth control in syngeneic mouse tumor models oleh Christopher Nirschl, Kristin Morris, Heather Brodkin, Nesreen Ismail, Andres Salmeron, Philipp Steiner, Zoe Steuert, Jenna Sullivan, William Winston, Cindy Seidel-Dugan, Ethika Tyagi, Josue Canales, Dan Hicklin
Diterbitkan 2021-11-01Artikel